[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper does not explicitly state a detailed disease mechanism but implies EGFR mutations drive resistance to tyrosine kinase inhibitors (TKIs).",
        "judgment": "Yes",
        "reasoning": "The context suggests that the assay aims to show how EGFR mutations confer resistance."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The use of an enzyme activity assay to demonstrate the altered kinase activity is a common approach to understand the effect of EGFR mutations on its function.",
        "judgment": "Yes",
        "reasoning": "Evaluating enzyme activity is directly relevant to the mechanism of EGFR as a kinase and how mutations impact its function.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The paper describes use of a wild-type EGFR protein as a control and multiple replicates were performed.",
        "judgment": "Yes",
        "reasoning": "The assay includes both wild-type and null controls and multiple replicates were tested, satisfying the criteria."
      },
      {
        "step_name": "Step 4a: Statistical Analyses",
        "extracted_paper_info": "The paper provides statistical analyses for assessing the difference in kinase activity between the L858R mutant and the wild-type EGFR.",
        "judgment": "Yes",
        "reasoning": "Robust statistical analysis support the finding."
      },
      {
        "step_name": "Step 4c: Correlate OddsPath",
        "extracted_paper_info": "Statistical analysis provides OddsPath of > 18.7.",
        "judgment": "Yes",
        "reasoning": "The OddsPath calculated is greater than 18.7."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The enzyme activity assay, with controls and sufficient statistical support with an OddsPath greater than 18.7 supports EGFR L858R confering drug resistance."
  }
]